Abnormal flow-mediated vasodilation in normal-tension glaucoma using a noninvasive determination for peripheral endothelial dysfunction

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 8, 2006, Pages 3390-3394

  Su, Wei Wen ^a   Cheng, Shih Tsung ^b   Hsu, Tsu Shiu ^a   Ho, Wan Jing ^a,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID; LIPID; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ENDOTHELIUM DEPENDENT FLOW MEDIATED VASODILATATION METHOD; ENDOTHELIUM LESION; FEMALE; GLAUCOMA; HUMAN; LIPID ANALYSIS; MALE; MULTIVARIATE ANALYSIS; NON INVASIVE MEASUREMENT; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REPRODUCIBILITY; VASODILATATION; BLOOD; BLOOD FLOW VELOCITY; BLOOD PRESSURE; DOPPLER ECHOGRAPHY; DRUG EFFECT; ELECTROCARDIOGRAPHY; GLUCOSE BLOOD LEVEL; HYPEREMIA; MIDDLE AGED; OPEN ANGLE GLAUCOMA; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

BLOOD FLOW VELOCITY; BLOOD GLUCOSE; BLOOD PRESSURE; BRACHIAL ARTERY; ELECTROCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; HYPEREMIA; LIPIDS; MALE; MIDDLE AGED; NITROGLYCERIN; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASODILATION; VASODILATOR AGENTS;

EID: 33748112474     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0024     Document Type: Article

References (36)

1. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA. 1991;266:369-374.
2. Hitchings RA. Low tension glaucoma: its place in modern glaucoma practice. Br J Ophthalmol. 1992;76:494-496.
3. Grosskreutz C, Netland PA. Low-tension glaucoma. Int Ophthalmol Clin. 1994;34:173-185.
4. Werner EB. Normal-tension glaucoma. In: Ritch SMB, Krupin T, eds. The Glaucomas. St. Louis: Mosby; 1996:768-797.
5. Hitchings RA, Anderton SA. A comparative study of visual field defects seen in patients with low-tension glaucoma and chronic simple glaucoma. Br J Ophthalmol. 1983;67:818-821.
6. Flammer J, Orgul S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21:359-393.
7. Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol. 1995;57:827-872.
8. Nakamura M, Yoshida H, Arakawa N, Hiramori K. Endothelium-dependent vasodilator response is augmented in peripheral resistance vessels of patients with vasospastic angina. Cardiology. 1999;92:85-92.
9. Sugiyama T, Moriya S, Oku H, Azuma I. Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies. Surv Ophthalmol. 1995;39(suppl 1):S49-S56.
10. Noske W, Hensen J, Wiederholt M. Endothelin-1-like immunoreactivity in aqueous humor of patients with primary open-angle glaucoma and cataract. Graefes Arch Clin Exp Ophthalmol. 1997;235:551-552.
11. Oku H, Sugiyama T, Kojima S, Watanabe T, Azuma I. Experimental optic cup enlargement caused by endothelin-1 induced chronic optic nerve head ischemia. Surv Ophthalmol. 1999;44(suppl 1):S74-S84.
12. Webb DJ, Haynes WG. Endothelins come to age. Lancet. 1993;342:1439-1440.
13. Palmer R, Ashton D, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
14. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
15. Henry E, Newby DE, Webb DJ, O'Brien C. Peripheral endothelial dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci. 1999;40:1710-1714.
16. Buckley C, Hadoke PWF, Henry E, O'Brien C. Systemic vascular endothelial cell dysfunction in normal pressure glaucoma. Br J Ophthalmol. 2002;86:227-232.
17. Anderson TJ, Elstein E, Haber H, Charbonneau F. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol. 2000;35:60-66.
18. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound, assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery, a report of the international brachial artery reactivity task force. J Am Coll Cardiol. 2002;39:257-265.
19. Johnson CA. Sample PA, Cioffi GA, Liebmann JR, Weinreb RN. Structure and function evaluation (SAFE): I criteria for glaucomatous visual field loss using standard automated perimetry (SAP) and short wavelength automated perimetry (SWAP). Am J Ophthalmol. 2002;134:177-185.
20. Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation. 2003;108:2054-2059.
21. Laurent S, Lacolley P, Brunel P, Laloux B, Pannier B, Safar M. Flow-dependent vasodilation of brachial artery in essential hypertension. Am J Physiol. 1990;258:H1004-H1011.
22. Anderson EA, Mark AL. Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation. 1989;79:93-100.
23. Celermajer DS, Sorensen KE, Gooch VM, et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
24. Sorensen KE, Celermajer DS, Spiegelhalter DJ, et al. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J. 1995;74:247-253.
25. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995;26:1235-1241.
26. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(suppl 1):III27-III32.
27. Verhaar MC, Honing ML, van-Dam T, et al. Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids. Cardiovasc Res. 1999;42:752-760.
28. The ENCORE Investigators. Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function). Circulation. 2003;107:422-428.
29. Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes. The Beaver Dam eye study. Ophthalmology. 1994;101:1173-1177.
30. Dielemans I, Vingerling JR, Algra D, Hofman A, Grobbee DE, de Jong PT. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology. 1995;102:54-60.
31. Wang JJ, Mitchell P, Smith W. Is there an association between migraine headache and open-angle glaucoma? Findings from the Blue Mountains Eye Study. Ophthalmology. 1997;104:1714-1719.
32. Phelps CD, Corbett JJ. Migraine and low-tension glaucoma: a casecontrol study. Invest Ophthalmol Vis Sci. 1985;26:1105-1108.
33. Kitazawa Y, Shirai H, Go FJ. The effect of Ca2(+)-antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 1989;227:408-412.
34. Netland PA, Chaturvedi N, Dreyer EB. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol. 1993;115:608-613.
35. Ishida K, Yamamoto T, Kitazawa Y. Clinical factors associated with progression of normal-tension glaucoma. J Glaucoma. 1998;7:372-377.
36. Koseki N, Araie M, Yamagami J, Shirato S, Yamamoto S. Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure. J Glaucoma. 1999;8:117-123.